DRMTY News and Press, Dr. Martens From 06/15/23

2023-06-15 00:04:22 ET Summary Dr. Martens has a loyal fanbase that continues to grow. Its high-quality production and timeless design are key value drivers. The company has achieved a CAGR of 43% in revenue and maintains a strong EBITDA margin of 20%. Dr. Martens is trading a...

2023-04-22 00:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A crisis-driven rotati...

2023-04-06 06:00:05 ET Summary Dr. Martens has seen a significant come-off in price in the past few months, which now makes its P/E look incredibly attractive compared to the consumer discretionary sector. However, the company faces softer demand and operational challenges that ha...

Summary The UK based boots' manufacturer Dr. Martens has seen a price fall of over 45% in the past year, despite sustained growth and good margins. Some fall in margins is expected as it makes investments, among other things, in e-commerce. But growth is expected to stay healthy. It...

Summary Markets declined during the third quarter as investors became convinced that monetary authorities would drive global economies into recession. The Strategy outperformed its benchmark due to its tilt towards “real economy” cyclical sectors, rather than defensi...

Summary Estimated an intrinsic value of $7.15b or $47 per share with a 1-year price target of $51, representing some 40% upside. Expansion focused on the direct-to-consumer strategy, India, South America, warehouse capacity and customer relationships. Margins will recover as f...